The effects of buspirone on occupancy of dopamine receptors and the rat gambling task (original) (raw)
Multiple and complex effects of buspirone on central dopaminergic system
Ada Luigi
Pharmacology Biochemistry and Behavior, 1988
View PDFchevron_right
Effects of buspirone on dopamine dependent behaviours in rats
ARCHANA DHAVALSHANKH
Indian journal of physiology and pharmacology
View PDFchevron_right
Buspirone affects hippocampal rhythmical slow activity through serotonin1A rather than dopamine D2 receptors
N. McNaughton
Neuroscience, 1991
View PDFchevron_right
Dopaminergic effects of buspirone, a novel anxiolytic agent
S. Garattini
Biochemical Pharmacology, 1983
View PDFchevron_right
Buspirone is a Major Active Metabolite of Buspirone : Assessment of Pharmacokinetics and 5-HT 1 A Receptor Occupancy in Rats
Suresh Yeola
2007
View PDFchevron_right
Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats
José Ruíz-ortega, Asier Aristieta
Neuropharmacology, 2014
View PDFchevron_right
Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone
Cesaria Prontera
British Journal of Pharmacology, 1989
View PDFchevron_right
Behavioral effects of acute and chronic buspirone
Joseph Wettstein
European Journal of Pharmacology, 1988
View PDFchevron_right
Behavioral and neurochemical studies on the anticonflict actions of buspirone
Jeffrey Witkin
Drug Development Research, 1984
View PDFchevron_right
Psychopharmacological Profile of Buspirone: A Critical Overview
ARCHANA DHAVALSHANKH
View PDFchevron_right
Acute and subchronic effects of buspirone on attention and impulsivity in the five-choice serial reaction time task in rats
Che-Se Tung
Neuroscience Letters, 2013
View PDFchevron_right
Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam
Gerard Marek
Psychopharmacology, 1994
View PDFchevron_right
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade
Claudio Bucolo
Frontiers in Pharmacology, 2017
View PDFchevron_right
Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors
Gavin Dawe
Neuropharmacology, 2016
View PDFchevron_right
Buspirone: What is it all about?
Marios Politis
Brain Research, 2012
View PDFchevron_right
Comparison of the effects of buspirone and chlordiazepoxide on differential reinforcement of low rates of response
Neil McNaughton
European Journal of Pharmacology, 1992
View PDFchevron_right
Lack of deleterious effects of buspirone on cognition in healthy male volunteers
Barbara Sahakian
Journal of Psychopharmacology, 2006
View PDFchevron_right
Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT1A receptors in rats
Alireza Mohajjel Nayebi
Pharmacological Reports, 2010
View PDFchevron_right
Effect of buspirone on rat plasma prolactin levels and striatal dopamine turnover
Miljana Petkovic
Psychopharmacology, 1982
View PDFchevron_right
Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment
Keith Young
Journal of Neural Transmission, 1991
View PDFchevron_right
The effect of chronic administration of buspirone on 6-hydroxydopamine-induced catalepsy in rats
Alireza Mohajjel Nayebi
Advanced pharmaceutical bulletin, 2012
View PDFchevron_right
Attenuation of apomorphine-induced sensitization by buspirone
Huma Ikram
Pharmacology Biochemistry and Behavior, 2011
View PDFchevron_right
Comparison of the effects of buspirone and chlordiazepoxide on successive discrimination
Neil McNaughton
Pharmacology Biochemistry and Behavior, 1991
View PDFchevron_right
Pre‐or post‐training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5‐HT1A receptors
Keng-chen Liang
European Journal of Neuroscience, 1999
View PDFchevron_right
Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm
Michael Nader
Psychopharmacology, 2014
View PDFchevron_right
Sustained 5-hydroxytryptamine release-inhibitory and anxiolytic-like action of the partial 5-HT1A receptor agonist, buspirone, after prolonged chronic administration
B. Söderpalm
European Journal of Pharmacology, 1993
View PDFchevron_right
Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats
Mirko Diksic
Neurochemistry International, 2009
View PDFchevron_right
Buspirone And Anxiety Disorders: A Review With Pharmacological And Clinical Perspectives
Farhat Batool
The Internet Journal of Pharmacology, 2008
View PDFchevron_right
Dose related effects of buspirone on pain, learning / memory and food intake
Darakhshan Haleem
Regulatory Toxicology and Pharmacology, 2018
View PDFchevron_right
Attenuation of methylphenidate-induced sensitization by co-administration of buspirone
Nausheen Alam
Pakistan journal of pharmaceutical sciences, 2016
View PDFchevron_right
Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats
javad mahmoudi
Pharmacological Reports, 2011
View PDFchevron_right